There was a trend for patients with mesangial sclerosis or high-grade IgG-C3 staining to achieve higher complete or partial response rates in the combination ACTH + tacrolimus group compared to ACTH alone; however, these differences did not reach statistical significance (Table 2). The gene discussed is POMC; the disease is Diffuse mesangial sclerosis.